Using an inflammation model, human cervical cancer cells, positive for HPV-16 and treated with lipopolysaccharide (LPS), have indeed displayed increased levels of NLRP3, IL-1β, processed IL-1β, and cleaved caspase-1 [167]. The gene discussed is IL1B; the disease is cervical carcinoma.